FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver ...
WEBSep 20, 2024 — Today, the U.S. Food and Drug Administration approved FluMist for self- or caregiver-administration. FluMist is approved for the prevention of influenza disease caused by influenza virus subtypes ...
FluMist approved for self-administration in the US
WEBSep 20, 2024 — FluMist has been approved in the US as the only self-administered influenza vaccine. FluMist, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or administered by a parent/caregiver to individuals 2-17 years of age. 1
FDA approves first self-administered flu vaccine spray - CBS News
WEBSeptember 20, 2024 / 4:05 PM EDT / CBS News. The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first "self-administered ...
No needles required: The FDA approves an at-home flu vaccine
WEBSep 20, 2024 — The Food and Drug Administration has approved the first flu vaccine that people can administer to themselves at home. The agency on Friday gave the green light for people who have been screened...
FDA approves first flu vaccine that can be self-administered at …
WEBSep 20, 2024 — The FDA approved FluMist as the first flu vaccine that can be self-administered at home. Sarah Silbiger/Getty Images. CNN —. The US Food and Drug Administration on Friday approved the first flu ...
At-home flu vaccine approved by FDA — what to know
WEB6 days ago — In a statement published Sept. 20, the FDA announced that it had approved the nasal spray influenza vaccine, called FluMist, for use at home. This allows people ages 18 to 49 to self-administer ...
FDA approves ‘FluMist,' says no healthcare provider needed
WEBSep 20, 2024 — The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for self-administration, making it the first of its kind. FluMist is the first vaccine to ...
FDA Approves Self-Administration of Influenza Vaccine FluMist
WEB5 days ago — The Food and Drug Administration (FDA) has approved at-home self- or caregiver-administration of FluMist (influenza vaccine live, intranasal). FluMist ® is a nasally-administered influenza vaccine that is indicated for active immunization to prevent influenza disease in individuals 2 to 49 years of age. The approval for self-administration was supported by data from a usability study that ...
FLUMIST approved for self-administration in the US
WEBSep 20, 2024 — FLUMIST® has been approved in the US as the only self-administered influenza vaccine. FLUMIST, a needle-free nasal spray, was approved to be self-admi.
FDA approves AstraZeneca's FluMist for self-administration
WEB6 days ago — FDA approves AstraZeneca FluMist flu vaccine for self-administration. The regulatory decision was informed by a comprehensive submission, including a usability study. September 23, 2024. The influenza vaccine can be self-administered by adults up to 49 years or given by a caregiver to those aged two to 17 years.